Disease criteria of systemic lupus erythematosus (SLE); the potential role of non-criteria autoantibodies
Open Access
- 11 January 2022
- journal article
- research article
- Published by Elsevier in Journal of Translational Autoimmunity
- Vol. 5, 100143
Abstract
No abstract availableKeywords
This publication has 136 references indexed in Scilit:
- Anti-ribosomal P protein IgG autoantibodies in patients with systemic lupus erythematosus: diagnostic performance and clinical profileBMC Medicine, 2013
- Antinucleosome antibodies as a potential biomarker for the evaluation of renal pathological activity in patients with proliferative lupus nephritisLupus, 2011
- Diagnostic value and clinical laboratory associations of antibodies against recombinant ribosomal P0, P1 and P2 proteins and their native heterocomplex in a Caucasian cohort with systemic lupus erythematosusArthritis Research & Therapy, 2011
- Lupus inducido por fármacosMedicina Clinica, 2010
- Ribosomal P autoantibodies are present before SLE onset and are directed against non-C-terminal peptidesJournal of Molecular Medicine, 2010
- Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosusArthritis Research & Therapy, 2009
- Limited reliability of the indirect immunofluorescence technique for the detection of anti-Rib-P antibodiesArthritis Research & Therapy, 2008
- The assembly of a spliceosomal small nuclear ribonucleoprotein particleNucleic Acids Research, 2008
- Necrotizing and Crescentic Lupus Nephritis with Antineutrophil Cytoplasmic Antibody SeropositivityClinical Journal of the American Society of Nephrology, 2008
- Autoantibodies Directed Against the Ribosomal P Proteins are not only Directed Against a Common Epitope of the P0, P1 and P2 ProteinsJournal of Autoimmunity, 1999